For this reason, CCL19 expression has been associated with the upregulation of adhesion molecules related to migration, the epithelial-to-mesenchymal transition (EMT), and metastasis in breast cancer, cervical cancer, pancreatic ductal adenocarcinoma, and ovarian cancer, among others [84,85,86,87]. This evidence concerns the gene CCL19 and breast cancer.